Not applicableStudy completedNCT00345228What this trial is testingMyopic Macular HaemorrhagesWho this might be right forMyopic Macular Haemorrhages Singapore National Eye Centre 30
Large-scale testing (Phase 3)Study completedNCT06176352What this trial is testingEvaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic MyopiaWho this might be right forChoroidal Neovascularization Secondary to Pathologic Myopia Hoffmann-La Roche 280
Post-approval studies (Phase 4)UnknownNCT02033018What this trial is testingAflibercept Intravitreal Injection for Myopic Choroidal NeovascularizationWho this might be right forChoroidal Retinal Neovascularization Instituto de Olhos de Goiania 20
Testing effectiveness (Phase 2)Study completedNCT04290195What this trial is testingUse of Ziv Aflibercept in Different Retinal DiseasesWho this might be right forCentral Retinal Vein Occlusion With Macular Edema Amin El Sayed Nawar 55
Early research (Phase 1)Study completedNCT00407719What this trial is testingBevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)Who this might be right forChoroidal NeovascularizationDegenerative MyopiaPathological Myopia Johns Hopkins University 10
Testing effectiveness (Phase 2)UnknownNCT04922151What this trial is testing601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)Who this might be right forPathological Myopic Choroidal Neovascularization Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Not applicableNot Yet RecruitingNCT07402629What this trial is testingDeep Learning-Based OCTA Quantification and Modeling for Predicting Long-Term Anti-VEGF Efficacy in mCNVWho this might be right forMyopic Choroidal Neovascularization Second Affiliated Hospital, Zhejiang University, School of Medicine 110
Testing effectiveness (Phase 2)Study completedNCT00470977What this trial is testingTreatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related MaculopathyWho this might be right forCoats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more Manhattan Eye, Ear & Throat Hospital 18
Not applicableUnknownNCT06357559What this trial is testingOCTA Changes in Choroidal Neovascularization in High MyopiaWho this might be right forMyopic Choroidal Neovascularisation Sohag University 100
Not applicableUnknownNCT05494775What this trial is testingEffect of Corona Virus on Intravitreal InjectionsWho this might be right forDiabetic Macular EdemaAge-Related Macular DegenerationChoroidal Neovascularization+2 more Benha University 250
Not applicableStudy completedNCT03971162What this trial is testingIntravitreal Conbercept Injection in Patients With Myopic Choroidal NeovascularizationWho this might be right forMyopic Choroidal Neovascularisation Zhongshan Ophthalmic Center, Sun Yat-sen University 50
Not applicableWithdrawnNCT01256580What this trial is testingIntravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMDWho this might be right forChoroidal NeovascularizationMyopiaPunctate Inner Choroidopathy (PIC)+5 more Massachusetts Eye and Ear Infirmary
Large-scale testing (Phase 3)Study completedNCT01922102What this trial is testingEfficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic MyopiaWho this might be right forVisual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM) Novartis Pharmaceuticals 457
Large-scale testing (Phase 3)UnknownNCT01809223What this trial is testingA Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNVWho this might be right forChoroid Neovascularization Secondary to Degenerative Myopia Chengdu Kanghong Biotech Co., Ltd. 176
Large-scale testing (Phase 3)Study completedNCT02034006What this trial is testingThe Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.Who this might be right forChoroidal Neovascularization Secondary to Pathologic Myopia Novartis Pharmaceuticals 200
Post-approval studies (Phase 4)Study completedNCT03409250What this trial is testingSD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to MyopiaWho this might be right forChoroidal NeovascularizationAge Related Macular Degeneration Vista Klinik 20
Early research (Phase 1)Study completedNCT01968486What this trial is testingReduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic MyopiaWho this might be right forMyopia, Degenerative University of Campania Luigi Vanvitelli 60
Not applicableStudy completedNCT02260687What this trial is testingSpecial Drug Use Investigation of EYLEA for Myopic Choroidal NeovascularizationWho this might be right forChoroidal Neovascularization Bayer 353
Not applicableStudy completedNCT03963596What this trial is testingAntiangiogenic Therapy of Choroidal Neovascularisation Associated With MyopiaWho this might be right forPathologic Myopia The Filatov Institute of Eye Diseases and Tissue Therapy 122
Early research (Phase 1)Study completedNCT00802126What this trial is testingIntravitreal Bevacizumab and Low Fluence Photodynamic TherapyWho this might be right forMyopia University of Campania Luigi Vanvitelli 16